Javascript must be enabled to continue!
Production of biopharmaceuticals and vaccines in plants via the chloroplast genome
View through CrossRef
AbstractTransgenic plants offer many advantages, including low cost of production (by elimination of fermenters), storage and transportation; heat stability; and absence of human pathogens. When therapeutic proteins are orally delivered, plant cells protect antigens in the stomach through bioencapsulation and eliminate the need for expensive purification and sterile injections, in addition to development of both systemic and mucosal immunity. Chloroplast genetic engineering offers several advantages, including high levels of transgene expression, transgene containment via maternal inheritance and multi‐gene expression in a single transformation event. Hyper‐expression of vaccine antigens against cholera, tetanus, anthrax, plague or canine parvovirus (4–31% of total soluble protein, tsp) in transgenic chloroplasts (leaves) or non‐green plastids (carrots, tomato), as well as the availability of antibiotic‐free selectable markers or the ability to excise selectable marker genes, facilitate oral delivery. Hyper‐expression of several therapeutic proteins, including human serum albumin (11.1% tsp), somatotropin (7% tsp), interferon‐gamma (6% tsp), anti‐microbial peptide (21.5% tsp), facilitates efficient and economic purification. Also, the presence of chaperones and enzymes in chloroplasts facilitate assembly of complex multi‐subunit proteins and correct folding of human blood proteins with proper disulfide bonds. Functionality of chloroplast‐derived vaccine antigens and therapeutic proteins has been demonstrated by several assays, including the macrophage lysis assay, GM1‐ganglioside binding assay, protection of HeLa cells or human lung carcinoma cells against encephalomyocarditis virus, systemic immune response, protection against pathogen challenge, and growth or inhibition of cell cultures. Thus, transgenic chloroplasts are ideal bioreactors for production of functional human and animal therapeutic proteins in an environmentally friendly manner.
Title: Production of biopharmaceuticals and vaccines in plants via the chloroplast genome
Description:
AbstractTransgenic plants offer many advantages, including low cost of production (by elimination of fermenters), storage and transportation; heat stability; and absence of human pathogens.
When therapeutic proteins are orally delivered, plant cells protect antigens in the stomach through bioencapsulation and eliminate the need for expensive purification and sterile injections, in addition to development of both systemic and mucosal immunity.
Chloroplast genetic engineering offers several advantages, including high levels of transgene expression, transgene containment via maternal inheritance and multi‐gene expression in a single transformation event.
Hyper‐expression of vaccine antigens against cholera, tetanus, anthrax, plague or canine parvovirus (4–31% of total soluble protein, tsp) in transgenic chloroplasts (leaves) or non‐green plastids (carrots, tomato), as well as the availability of antibiotic‐free selectable markers or the ability to excise selectable marker genes, facilitate oral delivery.
Hyper‐expression of several therapeutic proteins, including human serum albumin (11.
1% tsp), somatotropin (7% tsp), interferon‐gamma (6% tsp), anti‐microbial peptide (21.
5% tsp), facilitates efficient and economic purification.
Also, the presence of chaperones and enzymes in chloroplasts facilitate assembly of complex multi‐subunit proteins and correct folding of human blood proteins with proper disulfide bonds.
Functionality of chloroplast‐derived vaccine antigens and therapeutic proteins has been demonstrated by several assays, including the macrophage lysis assay, GM1‐ganglioside binding assay, protection of HeLa cells or human lung carcinoma cells against encephalomyocarditis virus, systemic immune response, protection against pathogen challenge, and growth or inhibition of cell cultures.
Thus, transgenic chloroplasts are ideal bioreactors for production of functional human and animal therapeutic proteins in an environmentally friendly manner.
Related Results
Inferring the evolutionary mechanism of the chloroplast genome size by comparing whole-chloroplast genome sequences in seed plants
Inferring the evolutionary mechanism of the chloroplast genome size by comparing whole-chloroplast genome sequences in seed plants
AbstractThe chloroplast genome originated from photosynthetic organisms and has retained the core genes that mainly encode components of photosynthesis. However, the causes of vari...
The accumulation of chloroplast small RNAs in unicellular alga
Chlamydomonas reinhardtii
is affected by nitrogen deprivation
The accumulation of chloroplast small RNAs in unicellular alga
Chlamydomonas reinhardtii
is affected by nitrogen deprivation
ABSTRACT
Small RNAs generated from the chloroplast genome may play a role in gene regulation. Given that chloroplast function is affected by nitr...
Hyperspectral imaging for chloroplast movement detection
Hyperspectral imaging for chloroplast movement detection
SummaryWe employed hyperspectral imaging to detect chloroplast positioning inNicotiana benthamianaandArabidopsis thalianaleaves and assess its influence on commonly used vegetation...
A systematic comparison of eight new plastome sequences from
Ipomoea
L
A systematic comparison of eight new plastome sequences from
Ipomoea
L
Background
Ipomoea
is the largest genus in the family Convolvulaceae. The species in this genus have been widely us...
A Comparative Analysis of the Chloroplast Genomes of Four Polygonum Medicinal Plants
A Comparative Analysis of the Chloroplast Genomes of Four Polygonum Medicinal Plants
Polygonum is a generalized genus of the Polygonaceae family that includes various herbaceous plants. In order to provide aid in understanding the evolutionary and phylogenetic rela...
Chloroplast phylogenomics and the dynamic evolution of Santalum (Santalaceae)
Chloroplast phylogenomics and the dynamic evolution of Santalum (Santalaceae)
Abstract
Background
Santalum (Santalaceae, sandalwood) is a hemiparasitic genus including approximately 15 extant species. It is known for its aromatic heartwood oil, whi...
Biopharmaceuticals—Current Information and New Challenges
Biopharmaceuticals—Current Information and New Challenges
Biopharmaceuticals are medical drugs produced by means of biotechnology. In contrast with small-molecule (traditional) drugs, which are usually synthesized chemically, biopharmaceu...
What are biopharmaceuticals?
What are biopharmaceuticals?
Throughout history, biopharmaceuticals have been essential in addressing health crises and enhancing human well-being. With advancements in genetic engineering, biotechnology, and ...

